Hjärnfondens (The Swedish Brain Foundation’s) Alzheimer Symposium
Welcome to a symposium about decoding molecular pathways and biomarkers for future therapies for Alzheimer's disease.
- 2025-04-09
- 08:15–17:00 (GMT+1)
- Aula Medica, Karolinska Institutet
The symposium will feature expert-led sessions, keynote lecture and in-depth discussions on novel biomarkers, neuroimaging, and drug development. Network with leading scientists and explore the latest breakthroughs in Alzheimer research.
Read more
Security – bags and items
Please note that no bags nor items larger than a A4 size (210 × 297 mm) are allowed. The symposium has a small cloakroom, but we ask you to avoid bringing bags/items larger than A4 size. Due to restricted space, we ask the participants to leave your luggage at your hotel before arriving at the symposium. For safety reasons, bicycle batteries are not allowed inside the venue.
Keynote speaker
Professor Bart de Strooper, VIB-KU Leuven Center for Brain & Disease Research, Belgium; UK Dementia Research Institute, University College London, UK.
Scientific and organizing commitee
- The Swedish Brain Foundation (Hjärnfonden)
- Professor Stina Syvänen, Uppsala University, Professor Janne Johansson, Karolinska Institute, Professor Martin Hallbeck, Linköping University, Professor Per Hammarström, Linköping University, Professor Christer Betsholtz, Karolinska Institute and Kaj Blennow, Gothenburg University
Program
| 8:15–9:00 |
Registration |
| 9:15–9:20 |
Introduction and welcome to the symposiumProfessor Cecilia Lundberg, |
| 9:20–10:05 |
Keynote lecture: Alzheimer’s disease: From molecular pathways to clinical hallmarksProfessor Bart De Strooper, |
| 10:05–11:50 |
SESSION I: The role of brain vasculature and amyloid fibril polymorphism in Alzheimer’s disease progressionChairs: Christer Betsholtz (KI) and Per Hammarström (LiU) 10:05–10:25 What role does the blood-brain barrier play in Alzheimer’s disease?Professor Christer Betsholtz, |
| 10:25–10:50 |
Coffee and mingle10:50–11:30 The potential for amyloid-beta transmission: What the evidence tells usAssociate Professor and Honorary Consultant Neuropathologist, Zane Jaunmuktane, 11:30–11:50 The role of fibril polymorphism of experimentally transmissible Aβ-amyloid seedsProfessor Per Hammarström, |
| 11:50–13:00 |
Lunch |
| 13:00–14:20 |
SESSION II: Novel Alzheimer’s biomarkers and mechanistic insights into disease progressionChairs: Kaj Blennow (GU) and Martin Hallbeck (LiU) 13:00–13:20 Aβ and tau AD biomarkers in CSF and blood – What do and don’t tell us about brain pathophysiologyProfessor Kaj Blennow, 13:20–13:40 Tau is tethered within EVs: Insights into the genesis of secreted tau species in human brainPhD Steph Fowler, 13:40–14:00 The role of autophagy in Alzheimer’s disease – Potential for treatmentAssociate Professor Per Nilsson, 14:00–14:20 From endosomes to vesicles: Cellular pathways driving Alzheimer’s diseaseProfessor Martin Hallbeck, |
| 14:20–15:00 |
Coffee and mingle |
| 15:00–16:20 |
SESSION III: Neuroimaging and drug development: Advancing novel treatment approaches for Alzheimer’s diseaseChairs: Stina Syvänen (UU) and Janne Johansson (KI) 15:00–15:40 TBDProfessor Tuomas Knowles, 15:40–16:00 Prevention of amyloid-associated neurotoxicity by the BRICHOS domain – Molecular mechanisms and therapeutic potentialProfessor Janne Johansson, 16:00–16:20 Bispecific antibody formats for neuroimaging and therapeuticsProfessor Stina Syvänen, |
| 16:20–16:40 |
Panel discussionModerator: Professor Cecilia Lundberg, |
| 16:40–16:45 |
Concluding remarks |
Contact
Emeli Lundström,
Scientific advisor
Phone: 08-525 255 59
E-mail: emeli.lundstrom@hjarnfonden.se
The 3rd Swedish Meeting for Alzheimer Research
Please also note that The 3rd Swedish Meeting for Alzheimer Research will be held on April 10, hosted by the Center for Alzheimer Research, CAR.
